Evidence map›Paper›PMID 30429939›Full record

SynthesisThe western journal of emergency medicine2018

The Emergency Department as an Opportunity for Naloxone Distribution.

Alexander H Gunn, Zachary P W Smothers, Nicole Schramm-Sapyta, Caroline E Freiermuth, Mark MacEachern, Andrew J Muzyk

Abstract readSystematic Review
In one paragraph

Synthesis in The western journal of emergency medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Take-home naloxone in multicentre emergency settings: the TIME feasibility cluster RCT.Health technology assessment (Winchester, England) · 2024
    Trial
  2. Trial
  3. Article
  4. Policy recommendations for overdose response hotlines and applications as a harm reduction tool: A commentary.Canadian journal of public health = Revue canadienne de sante publique · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Naloxone distribution programs in the emergency department: A scoping review of the literature.Journal of the American College of Emergency Physicians open · 2024
    Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexander H GunnDuke University, Duke-Margolis Center for Health Policy, Durham, North Carolina.
Zachary P W SmothersDuke University School of Medicine, Durham, North Carolina.
Nicole Schramm-SapytaDuke Institute for Brain Sciences, Department of Psychiatry, Duke University, Durham, North Carolina.
Caroline E FreiermuthDuke University School of Medicine, Division of Emergency Medicine, Durham, North Carolina.
Mark MacEachernTaubman Health Sciences Library, University of Michigan, Ann Arbor, Michigan.
Andrew J MuzykDuke University Hospital, Department of Pharmacy, Durham, North Carolina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSubstance use disorders, including opioid use disorders, are a major public health concern in the United States. Between 2005 and 2014, the rate of opioid-related emergency department (ED) visits nearly doubled, from 89.1 per 100,000 persons in 2005 to 177.7 per 100,000 persons in 2014. Thus, the ED presents a distinctive opportunity for harm-reduction strategies such as distribution of naloxone to patients who are at risk for an opioid overdose.

methodsWe conducted a systematic review of all existing literature related to naloxone distribution from the ED. We included only those articles published in peer-reviewed journals that described results relating to naloxone distribution from the ED.

resultsOf the 2,286 articles we identified from the search, five met the inclusion criteria and had direct relevance to naloxone distribution from the ED setting. Across the studies, we found variation in the methods of implementation and evaluation of take-home naloxone programs in the ED. In the three studies that attempted patient follow-up, success was low, limiting the evidence for the programs' effectiveness. Overall, in the included studies there is evidence that distributing take-home naloxone from the ED has the potential for harm reduction; however, the uptake of the practice remained low. Barriers to implementation included time allocated for training hospital staff and the burden on workflow.

conclusionThis systematic review of the best evidence available supports the ED as a potential setting for naloxone distribution for overdose reversal in the community. The variability of the implementation methods across the studies highlights the need for future research to determine the most effective practices.

Indexed as

Drug OverdoseEmergency Service, HospitalHumansNaloxoneNarcotic AntagonistsOpioid-Related DisordersProgram EvaluationUnited StatesNaloxoneNarcotic Antagonists

Identifiers

PMID30429939
PMCPMC6225944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.